Recent experience with fungaemia: Change in species distribution and azole resistance

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 4, 2009, Pages 275-284

  Chakrabarti, Arunaloke ^a   Chatterjee, Shiv Sekhar ^a   Rao, K L N ^a   Zameer, M M ^a   Shivaprakash, M R ^a   Singhi, Sunit ^a   Singh, Rajinder ^a   Varma, Shubhash Chandra ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE; TRIAZOLE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA PELLICULOSA; CANDIDA TROPICALIS; CANDIDA USTUS; CHILD; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGEMIA; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEWBORN; NONHUMAN; PREMATURITY; SPECIES DISTRIBUTION; SURGERY; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CANDIDIASIS; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; DRUG RESISTANCE, FUNGAL; FUNGEMIA; HUMANS; INDIA; RISK FACTORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 66849127708     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540902777105     Document Type: Article

References (42)

1. Abi-Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H. and Vartivarian, S. (1997) The epidemiology of haematogenous candidiasis caused by different Candida spp. Clin Infect Dis, 24, pp. 1122-1128.
2. Pfaller, MA and Diekema, DJ. (2007) Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev, 20, pp. 133-163.
3. Edmond, MB, Wallace, SE, McClish, DK, Pfaller, MA, Jones, RN and Wenzel, RP. (1999) Nosocomial bloodstream infections in United States hospitals: a 3-y analysis. Clin Infect Dis, 29, pp. 239-244.
4. Harvey, RL and Myers, JP. (1987) Nosocomial fungaemia in a large community teaching hospital. Arch Intern Med, 147, pp. 2117-2120.
5. Rex, JH, Bennett, JE, Sugar, AM, Pappas, PG, van der Horst, CM Edwards, JE et al. (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidaemia in patients without neutropenia. Candidaemia Study Group and the National Institute. N Eng J Med, 331, pp. 1325-1330.
6. Trick, WE, Fridkin, SK, Edwards, JR, Hajjeh, RA and Gaynes, RP. (2002) National Nosocomial Infections Surveillance System, Hospitals. Secular trend of hospital acquired candidaemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis, 35, pp. 627-630.
7. Pappas, PG, Rex, JH, Sobel, JD, Filler, SG, Dismukes, WE, Walsh, TJ and Edwards, JE. (2004) Infectious Diseases Society of America. Guidelines for the treatment of candidiasis. Clin Infect Dis, 38, pp. 161-189.
8. Malani, A., Hmoud, J., Chiu, L., Carver, PL, Bielaczyc, A. and Kauffman, CA. (2005) Candida glabrata fungaemia: Experience in a tertiary care centre. Clin Infect Dis, 41, pp. 975-981.
9. Trofa, D., Gacser, A. and Nosanchuk, JD. (2008) Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev, 21, pp. 606-625.
10. Chakrabarti, A., Ghosh, A., Batra, R., Kaushal, A., Roy, P. and Singh, H. (1996) Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5-y period. Indian J Med Res, 104, pp. 171-176.
11. Prasad, KN, Agarwal, J., Dixit, AK, Tiwari, DP, Dhole, TN and Ayyagari, A. (1999) Role of yeasts as nosocomial pathogen and their susceptibility to fluconazole and amphotericin B. Indian J Med Res, 110, pp. 11-17.
12. Chakrabarti, A., Mohan, B., Shrivastava, SK, Marak, RS, Ghosh, A. and Ray, P. (2002) Change in distribution and antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care centre during 1996-2000. Indian J Med Res, 116, pp. 5-12.
13. Rani, R., Mohapatra, NP, Mehta, G. and Randhawa, VS. (2002) Changing trends of Candida species in neonatal septicaemia in a tertiary care north Indian hospital. Indian J Med Microbiol, 20, pp. 42-44.
14. Verma, AK, Prasad, KN, Singh, M., Dixit, AK and Ayyagari, A. (2003) Candidaemia in patients of a tertiary health care hospital from north India. Indian J Med Res, 117, pp. 122-128.
15. Chakrabarti, A., Singh, K., Narang, A., Singhi, S., Batra, R. Rao, KL et al. (2001) Outbreak of Pichia anomala infection in the paediatric service of a tertiary care centre in northern India. J Clin Microbiol, 39, pp. 1702-1706.
16. Hazen, KC and Howell, SA. (2003) Candida, Cryptococcus, and other yeasts of medical importance. Manual of Clinical Microbiology, 2, pp. 1693-1711. ASM Press, Washington DC, USA
17. National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. 2nd edn.
18. Pfaller, MA, Diekema, DJ, Rex, JH, Espinel-Ingroff, A., Johnson, EM Andes, D. et al. (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints. J Clin Microbiol, 44, pp. 819-826.
19. Chakrabarti, A., Chander, J., Kasturi, P. and Panigrahi, D. (1992) Candidaemia: A 10-y study in an Indian teaching hospital. Mycoses, 35, pp. 47-51.
20. Pappas, PG, Rex, JH, Lee, J., Hamill, RJ, Larsen, RA Powderly, W. et al. (2003) A prospective observational study of candidaemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and paediatric patients. Clin Infect Dis, 37, pp. 634-643.
21. Blumberg, HM, Jarvis, WR, Soucie, JM, Edwards, JE, Patterson, JE Pfaller, MA et al. (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicentre study. The National Epidemiology of Mycosis Survey. Clin Infect Dis, 33, pp. 177-186.
22. Sobel, JD and Rex, JH. (2001) Invasive candidiasis: Turning risk into practical prevention policy?. Clin Infect Dis, 33, pp. 187-190.
23. Ostrosky-Zeichner, L. and Pappas, PG. (2006) Invasive candidiasis in the intensive care unit. Crit Care Med, 34, pp. 857-863.
24. Pfaller, MA. (1996) Nosocomial candidiasis: Emerging species, reservoirs, and modes of transmission. Clin Infect Dis, 22, p. S89.
25. Rangel-Frausto, MS, Wiblin, T., Blumberg, HM, Saiman, L., Patterson, J. Rinaldi, M. et al. (1999) National Epidemiology of Mycoses Survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in 7 surgical intensive care units and 6 neonatal intensive care units. Clin Infect Dis, 29, pp. 253-258.
26. Chakrabarti, A., Singh, K. and Das, S. (1999) Changing face of nosocomial candidaemia. Indian J Med Microbiol, 17, pp. 160-166.
27. Colombo, AL, Nucci, M., Salomao, R., Branchini, ML, Richtmann, R., Derossi, A. and Wey, SB. (1999) High rate of non-albicans candidaemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis, 34, pp. 281-286.
28. Pfaller, MA, Diekema, DJ, Mendez, M., Kibbler, C., Erzsebet, P. Chang, SC et al. (2006) Candida guillermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: Geographic and temporal trends from the ARTEMIS Disk Antifungal Surveillance Programme. J Clin Microbiol, 44, pp. 3551-3556.
29. Masala, L., Luzzati, R., Maccacaro, L., Antozzi, L., Concia, E. and Fontana, R. (2003) Nosocomial cluster of Candida guillermondii fungaemia in surgical patients. Eur J Clin Microbiol Infect Dis, 22, pp. 686-688.
30. Aragao, PA, Oshiro, IC, Manrique, EI, Gomes, CC, Matsuo, LL Leone, C. et al. (2001) IRIS Study Group. Pichia anomala outbreak in a nursery: exogenous source?. Pediatr Infect Dis J, 20, pp. 843-848.
31. Kalenic, S., Jandrlic, M., Vegar, V., Zuech, N., Sekulic, A. and Mlinaric-Missoni, E. (2001) Hansenula anomala outbreak at a surgical intensive care unit: A search for risk factors. Eur J Epidemiol, 17, pp. 491-496.
32. Pasqualotto, AC, Sukiennik, TC, Severo, LC, de Amorim, CS and Colombo, AL. (2005) An outbreak of Pichia anomala fungaemia in a Brazilian paediatric intensive care unit. Infect Control Hosp Epidemiol, 26, pp. 553-558.
33. Rex, JH and Pfaller, MA. (2002) Has antifungal susceptibility testing come of age?. Clin Infect Dis, 35, pp. 982-989.
34. Alexander, BD and Pfaller, MA. (2006) Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis, 43, p. S15.
35. Antoniadou, A., Torres, HA, Lewis, RE, Thornby, J., Bodey, GP Tarrand, JJ et al. (2003) Candidaemia in a tertiary care cancer centre: In vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine, 82, pp. 309-321.
36. Pfaller, MA, Diekema, DJ and Sheehan, DJ. (2006) Interpretative breakpoints for fluconazole and Candida revisited: A blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev, 19, pp. 435-447.
37. Pfaller, MA, Diekema, DJ, Rinaldi, MG, Barnes, R., Hu, B. Veselov, AV et al. (2005) Results from ARTEMIS DISK Global Antifungal surveillance study: A 6.5-y analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standard disk diffusion testing. J Clin Microbiol, 43, pp. 5848-5859.
38. Pfaller, MA, Messer, SA, Boyken, L., Hollis, RJ, Rice, C. Tendolkar, S. et al. (2004) In vitro activities of voriconazole, posaconazole, and fluconazole against 4169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS Global Antifungal Surveillance Programme. Diagn Microbiol Infect Dis, 48, pp. 201-205.
39. Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R. and Fadda, G. (2005) Mechanism of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chenotherer, 49, pp. 668-679.
40. Pfaller, MA, Boyken, L., Hollis, RJ, Messer, SA, Tendolkar, S. and Diekema, DJ. (2006) In vitro susceptibilities of Candida spp. to caspofungin: 4 y of global surveillance. J Clin Microbiol, 44, pp. 760-763.
41. Gafter-Gvili, A., Vidal, L., Goldberg, S., Leibovici, L. and Paul, M. (2008) Treatment of invasive candidal infections: Systematic review and meta-analysis. Mayo Clinic Proc, 83, pp. 1011-1021.
42. Baddley, JW, Patel, M., Jones, M., Cloud, G., Smith, AC and Moser, SA (2004) Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidaemia. Diagn Microbiol Infect Dis, 50, pp. 119-124.